Novel lncRNAs with diagnostic or prognostic value screened out from breast cancer via bioinformatics analyses
Authors:
Open Access
Abstract
Background: Recent studies have shown that long non-coding RNAs (lncRNAs) may play key regulatory roles in many malignant tumors. This study investigated the use of novel lncRNA biomarkers in the diagnosis and prognosis of breast cancer. Materials and Methods: The database subsets of The Cancer Genome Atlas (TCGA) by RNA-seq for comparing analysis of tissue samples between breast cancer and normal control groups were downloaded. Additionally, anticoagulant peripheral blood samples were collected and used in this cohort study. The extracellular vesicles (EVs) from the plasma were extracted and sequenced, then analyzed to determine the expressive profiles of the lncRNAs, and the cancer-related differentially expressed lncRNAs were screened out. The expressive profiles and associated downstream-mRNAs were assessed using bioinformatics (such as weighted correlation network analysis (WGCNA), Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genome (KEGG) enrichments, Receiver-Operating Characteristic (ROC) curve and survival analysis, etc.) to investigate the diagnostic and prognostic values of these EV lncRNAs and their effectors. Results: In this study, 41 breast cancer-related lncRNAs were screen out from two datasets of tissue and fresh collected plasma samples of breast cancer via the transcriptomic and bioinformatics techniques. A total of 19 gene modules were identified with WGCNA analysis, of which five modules were significantly correlated with the clinical stage of breast cancer, including 28 lncRNA candidates. The ROC curves of these lncRNAs revealed that the area under the curve (AUC) of all candidates were great than 70%. However, eight lncRNAs had an AUC >70%, indicating that the combined one has a good diagnostic value. In addition, the results of survival analysis suggested that two lncRNAs with low expressive levels may indicate the poor prognosis of breast cancer. By tissue sample verification, C15orf54, AL157935.1, LINC01117, and SNHG3 were determined to have good diagnostic ability in breast cancer lesions, however, there was no significant difference in the plasma EVs of patients. Moreover, survival analysis data also showed that AL355974.2 may serve as an independent prognostic factor and as a protective factor. Conclusion: A total of five lncRNAs found in this study could be developed as biomarkers for breast cancer patients, including four diagnostic markers (C15orf54, AL157935.1, LINC01117, and SNHG3) and a potential prognostic marker (AL355974.2).Keywords
Funding Information
- Nanshan District Government of Shenzhen City (2018012)
- Shenzhen University, P.R. China
This publication has 45 references indexed in Scilit:
- Modern maize varieties going local in the semi-arid zone in TanzaniaBMC Ecology and Evolution, 2014
- The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancerBMC Cancer, 2013
- The Long Non-Coding RNAs: A New (P)layer in the “Dark Matter”Frontiers in Genetics, 2012
- Molecular Mechanisms of Long Noncoding RNAsMolecular Cell, 2011
- Breast cancer screening in women: An integrative literature reviewJournal of the American Academy of Nurse Practitioners, 2010
- Transcribed dark matter: meaning or myth?Human Molecular Genetics, 2010
- Long noncoding RNAs: functional surprises from the RNA worldGenes & Development, 2009
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for RBioinformatics, 2007
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005